Fig. 8.
Fig. 8. IL-6 bioactivity, measured by [3H]-TdR uptake in 7TD1 cells, in supernatants from BALB/c BMCMCs that had been stimulated for 2 hours with rrSCF or IgE/DNP; supernatants were tested with (+) or without (−) prior incubation with an anti–IL-6 antibody. The mean baseline value for 7TD1 cells incubated without a source of IL-6 (898 cpm) was subtracted before showing cpm data as mean ± SEM (n = 3). *P < .05, **P < .005 versus corresponding values without anti–IL-6 antibody; †, not significant (P < .05) versus baseline values (898 ± 114 cpm) for negative control 7TD1 cells incubated without IL-6.

IL-6 bioactivity, measured by [3H]-TdR uptake in 7TD1 cells, in supernatants from BALB/c BMCMCs that had been stimulated for 2 hours with rrSCF or IgE/DNP; supernatants were tested with (+) or without (−) prior incubation with an anti–IL-6 antibody. The mean baseline value for 7TD1 cells incubated without a source of IL-6 (898 cpm) was subtracted before showing cpm data as mean ± SEM (n = 3). *P < .05, **P < .005 versus corresponding values without anti–IL-6 antibody; †, not significant (P < .05) versus baseline values (898 ± 114 cpm) for negative control 7TD1 cells incubated without IL-6.

Close Modal

or Create an Account

Close Modal
Close Modal